Patient-Specific Approach to Combination Versus Monotherapy with the Use of Antitumor Necrosis Factor α Agents for Inflammatory Bowel Disease

Patient-Specific Approach to Combination Versus Monotherapy with the Use of Antitumor Necrosis Factor α Agents for Inflammatory Bowel Disease

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Gastroenterology Clinics of North America - Volume 41, Issue 2, June 2012, Pages 411-428

Shane M. MD, FRCPC, Adam S. MD, Corey A. MD, MS, BRIDGe group BRIDGe group,